| abstract |
The invention provides a method of treating or preventing mucormycosis in a subject in need thereof, comprising administering to the subject a therapeutically- effective amount of an agent that inhibits a signaling pathway of a receptor selected from the group consisting of epidermal growth factor receptor, platelet derived growth factor receptor, ErbB2/Her2, progesterone receptor and a combination thereof. |